Stock Scorer

Healthequity, Inc. (HQY)

Healthequity, Inc. reported revenue of 354.6M USD for the quarter ending 30 April 2026, up 7.2% from 330.8M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 01-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 April 2026 354.6M +7.2%
Gross Profit Q2 '26 · ending 30 April 2026 256.3M +14.3%
Operating Income Q2 '26 · ending 30 April 2026 103M +23.9%
Net Income Q2 '26 · ending 30 April 2026 69.4M +28.8%
Cost of Revenue Q2 '26 · ending 30 April 2026 98.3M -7.7%
Operating Cash Flow Q2 '26 · ending 30 April 2026 97.5M +50.6%
Free Cash Flow Q2 '26 · ending 30 April 2026 97.2M +50.3%
Shares Outstanding Q2 '26 · ending 30 April 2026 85M -4.1%
EPS Q2 '26 · ending 30 April 2026 2.67 +94.9%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20262026-01-31 1.3B322.5M215.2M455.1M
20252025-01-31 1.2B162.3M96.7M337.8M
20242024-01-31 999.6M117.7M55.7M241.1M
20232023-01-31 861.7M9.1M-26.1M147.3M
20222022-01-31 756.6M-24.2M-44.3M132.1M
20212021-01-31 733.6M34M8.8M168.5M
20202020-01-31 532M77M39.7M97.7M
20192019-01-31 287.2M77.7M73.9M109.6M
20182018-01-31 229.5M54.4M47.4M76.2M
20172017-01-31 178.4M41.2M26.4M41.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q1 '272026-04-30354.6M
Q4 '262026-01-31334.6M
Q3 '262025-10-31322.2M
Q2 '262025-07-31325.8M
Q1 '262025-04-30330.8M
Q4 '252025-01-31311.8M
Q3 '252024-10-31300.4M
Q2 '252024-07-31299.9M
Q1 '252024-04-30287.6M
Q4 '242024-01-31262.4M
Q3 '242023-10-31249.2M
Q2 '242023-07-31243.5M
Q1 '242023-04-30244.4M
Q4 '232023-01-31233.8M
Q3 '232022-10-31216.1M
Q2 '232022-07-31206.1M
Q1 '232022-04-30205.7M
Q4 '222022-01-31203.3M
Q3 '222021-10-31180M
Q2 '222021-07-31189.1M

Gross Profit Quarterly

PeriodEndingGross Profit
Q1 '272026-04-30256.3M
Q4 '262026-01-31228.1M
Q3 '262025-10-31228.1M
Q2 '262025-07-31232.6M
Q1 '262025-04-30224.3M
Q4 '252025-01-31189M
Q3 '252024-10-31197M
Q2 '252024-07-31204.1M
Q1 '252024-04-30187.1M
Q4 '242024-01-31163.3M
Q3 '242023-10-31159.2M
Q2 '242023-07-31151.7M
Q1 '242023-04-30148.5M
Q4 '232023-01-31134.8M
Q3 '232022-10-31126.9M
Q2 '232022-07-31117.8M
Q1 '232022-04-30111.2M
Q4 '222022-01-31105.6M
Q3 '222021-10-31103.3M
Q2 '222021-07-31112M

Operating Income Quarterly

PeriodEndingOperating Income
Q1 '272026-04-30103M
Q4 '262026-01-3171.1M
Q3 '262025-10-3178.7M
Q2 '262025-07-3189.6M
Q1 '262025-04-3083.1M
Q4 '252025-01-3142.1M
Q3 '252024-10-3119.6M
Q2 '252024-07-3158.9M
Q1 '252024-04-3041.6M
Q4 '242024-01-3138.9M
Q3 '242023-10-3130.9M
Q2 '242023-07-3124.7M
Q1 '242023-04-3023.2M
Q4 '232023-01-3113.2M
Q3 '232022-10-315.5M
Q2 '232022-07-31-2.4M
Q1 '232022-04-30-7.3M
Q4 '222022-01-31-27.2M
Q3 '222021-10-31-366K
Q2 '222021-07-31-875K

Net Income Quarterly

PeriodEndingNet Income
Q1 '272026-04-3069.4M
Q4 '262026-01-3149.7M
Q3 '262025-10-3151.7M
Q2 '262025-07-3159.9M
Q1 '262025-04-3053.9M
Q4 '252025-01-3126.4M
Q3 '252024-10-315.7M
Q2 '252024-07-3135.8M
Q1 '252024-04-3028.8M
Q4 '242024-01-3126.4M
Q3 '242023-10-3114.7M
Q2 '242023-07-3110.6M
Q1 '242023-04-304.1M
Q4 '232023-01-31-209K
Q3 '232022-10-31-1.6M
Q2 '232022-07-31-10.7M
Q1 '232022-04-30-13.6M
Q4 '222022-01-31-32.8M
Q3 '222021-10-31-5M
Q2 '222021-07-31-3.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q1 '272026-04-3098.3M
Q4 '262026-01-31106.4M
Q3 '262025-10-3194.1M
Q2 '262025-07-3193.2M
Q1 '262025-04-30106.5M
Q4 '252025-01-31122.8M
Q3 '252024-10-31103.4M
Q2 '252024-07-3195.9M
Q1 '252024-04-30100.5M
Q4 '242024-01-3199.1M
Q3 '242023-10-3190M
Q2 '242023-07-3191.9M
Q1 '242023-04-3096M
Q4 '232023-01-3199.1M
Q3 '232022-10-3189.2M
Q2 '232022-07-3188.3M
Q1 '232022-04-3094.5M
Q4 '222022-01-3197.7M
Q3 '222021-10-3176.6M
Q2 '222021-07-3177.1M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q1 '272026-04-3097.5M
Q4 '262026-01-31117.9M
Q3 '262025-10-31138.6M
Q2 '262025-07-31135.9M
Q1 '262025-04-3064.7M
Q4 '252025-01-3175.7M
Q3 '252024-10-3190.5M
Q2 '252024-07-31108.1M
Q1 '252024-04-3065.4M
Q4 '242024-01-3177.1M
Q3 '242023-10-3157.1M
Q2 '242023-07-3177.1M
Q1 '242023-04-3031.5M
Q4 '232023-01-3155.5M
Q3 '232022-10-3147.9M
Q2 '232022-07-3140.1M
Q1 '232022-04-307.1M
Q4 '222022-01-3150.6M
Q3 '222021-10-3122.3M
Q2 '222021-07-3137.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q1 '272026-04-3097.2M
Q4 '262026-01-31117.6M
Q3 '262025-10-31137.8M
Q2 '262025-07-31135.1M
Q1 '262025-04-3064.7M
Q4 '252025-01-3175.4M
Q3 '252024-10-3190.3M
Q2 '252024-07-31107.4M
Q1 '252024-04-3064.7M
Q4 '242024-01-3176.5M
Q3 '242023-10-3156.6M
Q2 '242023-07-3176.6M
Q1 '242023-04-3031.4M
Q4 '232023-01-3155.1M
Q3 '232022-10-3147.3M
Q2 '232022-07-3138.9M
Q1 '232022-04-305.9M
Q4 '222022-01-3148.9M
Q3 '222021-10-3121.3M
Q2 '222021-07-3133.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q1 '272026-04-3085M
Q3 '262025-10-3187M
Q2 '262025-07-3187.7M
Q1 '262025-04-3088.4M
Q3 '252024-10-3188.6M
Q2 '252024-07-3188.6M
Q1 '252024-04-3088.3M
Q3 '242023-10-3187.1M
Q2 '242023-07-3186.3M
Q1 '242023-04-3086.1M
Q3 '232022-10-3184.6M
Q2 '232022-07-3184.4M
Q1 '232022-04-3084M
Q3 '222021-10-3183.6M
Q2 '222021-07-3183.5M
Q1 '222021-04-3081.7M
Q3 '212020-10-3177.8M
Q2 '212020-07-3172.3M
Q1 '212020-04-3072.3M
Q3 '202019-10-3170.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '272026-04-302.67
Q4 '262026-01-312.46
Q3 '262025-10-312.18
Q2 '262025-07-311.65
Q1 '262025-04-301.37
Q4 '252025-01-311.09
Q3 '252024-10-311.09
Q2 '252024-07-311.20
Q1 '252024-04-300.92
Q4 '242024-01-310.64
Q3 '242023-10-310.34
Q2 '242023-07-310.15
Q1 '242023-04-30-0.10
Q4 '232023-01-31-0.31
Q3 '232022-10-31-0.70
Q2 '232022-07-31-0.74
Q1 '232022-04-30-0.66
Q4 '222022-01-31-0.53
Q3 '222021-10-31-0.07
Q2 '222021-07-310.01